Jiaji Yu - Concepedia

Author

Jiaji Yu

University of California, Los Angeles ORCID

Also Known As

Jiaji Yu

Publications

835

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles Broad Center University of Southern California Parker Institute for Cancer Immunotherapy Kunming Medical University

About

Jiaji Yu is an author at University of California, Los Angeles specializing in medicine, cellular therapies, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	114
2	Cell Biology	2	2	114
3	Cellular Therapies	2	2	114
4	Engineering	1	1	24
5	Biomedical Engineering	1	1	24

Jiaji Yu

Publications

801

Citations

H-Index

Page 1

	Year	Citations
Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy Yu-Chen Wang, Xi Wang, Jiaji Yu, Nature Communications	2021	145
Creatine uptake regulates CD8 T cell antitumor immunity Stefano Di Biase, Xiaoya Ma, Xi Wang, The Journal of Experimental Medicine	2019	118
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy Yan-Ruide Li, Yang Zhou, Yanni Zhu, Cell Reports Medicine	2021	95
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer Yanni Zhu, Drake J. Smith, Yang Zhou, Cell stem cell Cell TherapyMedicineStem Cell MobilizationT-regulatory CellImmunology	2019	90
Targeting monoamine oxidase A for T cell–based cancer immunotherapy Xi Wang, Bo Li, Yu-Chen Wang, Science Immunology	2021	73
Isolation and characterization of NY-ESO-1–specific T cell receptors restricted on various MHC molecules Michael T. Bethune, Xiaohua Li, Jiaji Yu, Proceedings of the National Academy of Sciences	2018	69
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method Yan-Ruide Li, Yang Zhou, Jiaji Yu, Nature Biotechnology	2024	67
Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers Yan-Ruide Li, Samuel Zeng, Zachary Spencer Dunn, iScience	2022	36
Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention Yan-Ruide Li, Zachary Spencer Dunn, Gustavo Garcia, Stem Cell Research & Therapy	2022	33
Ophiocordyceps lanpingensis polysaccharides attenuate pulmonary fibrosis in mice Shubo Zhou, Yongchun Zhou, Jiaji Yu, Biomedicine & Pharmacotherapy	2020	25

Page 1